Differential Influence of Dietary Soy Intake on the Risk of Breast Cancer Recurrence Related to HER2 Status

REFERENCES

• Messina , M J . 1999 . Legumes and soybeans: overview of their nutritional profiles and health effects . Am J Clin Nutr , 70 : 439S – 450S .
   PubMed Web of Science ®Google Scholar
• Lee , S A , Shu , X O , Li , H , Yang , G Cai , H . 2009 . Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study . Am J Clin Nutr , 89 : 1920 – 1926 .
   PubMed Web of Science ®Google Scholar
• Yamamoto , S , Sobue , T , Kobayashi , M , Sasaki , S and Tsugane , S . 2003 . Soy, isoflavones, and breast cancer risk in Japan . J Natl Cancer Inst , 95 : 906 – 913 .
   PubMed Web of Science ®Google Scholar
• Cho , Y , Kim , J , Park , K , Lim , S Shin , A . 2010 . Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status . Eur J Clin Nutr , 64 : 924 – 932 .
   PubMed Web of Science ®Google Scholar
• Fink , B N , Steck , S E , Wolff , M S , Britton , J A Kabat , G C . 2007 . Dietary flavonoid intake and breast cancer survival among women on Long Island . Cancer Epidem Biomar , 16 : 2285 – 2292 .
   PubMed Web of Science ®Google Scholar
• Trock , B J , Hilakivi-Clarke , L and Clarke , R . 2006 . Meta-analysis of soy intake and breast cancer risk . J Natl Cancer Inst , 98 : 459 – 471 .
   PubMed Web of Science ®Google Scholar
• Wu , A , Yu , M , Tseng , C and Pike , M . 2008 . Epidemiology of soy exposures and breast cancer risk . Br J Cancer , 98 : 9 – 14 .
   PubMed Web of Science ®Google Scholar
• Dong , J Y and Qin , L Q . 2011 . Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies . Breast Cancer Res Tr , 125 : 315 – 323 .
   PubMed Web of Science ®Google Scholar
• Boyapati , S M , Shu , X , Ruan , Z X , Dai , Q Cai , Q . 2005 . Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study . Breast Cancer Res Tr , 92 : 11 – 17 .
   PubMed Web of Science ®Google Scholar
• Shu , X O , Zheng , Y , Cai , H , Gu , K Chen , Z . 2009 . Soy food intake and breast cancer survival . JAMA , 302 : 2437 – 2443 .
   PubMed Web of Science ®Google Scholar
• Kang , X , Zhang , Q , Wang , S , Huang , X and Jin , S . 2010 . Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy . CMAJ , 182 : 1857 – 1862 .
   PubMed Web of Science ®Google Scholar
• Shou , J , Massarweh , S , Osborne , C K , Wakeling , A E Ali , S . 2004 . Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer . J Natl Cancer Inst , 96 : 926 – 935 .
   PubMed Web of Science ®Google Scholar
• Yang , X , Yang , S , McKimmey , C , Liu , B Edgerton , S . 2010 . Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation . Carcinogenesis , 31 : 695 – 702 .
   PubMed Web of Science ®Google Scholar
• Onitilo , A A , Engel , J M , Greenlee , R T and Mukesh , B N . 2009 . Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival . Clin Med Res , 7 : 4 – 13 .
   PubMedGoogle Scholar
• Kang , S P , Martel , M and Harris , L N . 2008 . Triple negative breast cancer: current understanding of biology and treatment options . Curr Opin Oestet Gyn , 20 : 40 – 46 .
   PubMed Web of Science ®Google Scholar
• Anders , C and Carey , L A . 2008 . Understanding and treating triple-negative breast cancer . Oncology–NY , 22 : 1233 – 1243 .
   PubMed Web of Science ®Google Scholar
• Ahn , Y , Kwon , E , Shim , J , Park , M Joo , Y . 2007 . Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study . Eur J Clin Nutr , 61 : 1435 – 1441 .
   PubMed Web of Science ®Google Scholar
• Park , M K , Song , Y , Joung , H , Li , S and Paik , H Y . 2007 . Establishment of an isoflavone database for usual Korean foods and evaluation of isoflavone intake among Korean children . Asia Pac J Clin Nutr , 16 : 129 – 139 .
   PubMed Web of Science ®Google Scholar
• Nam , B H , Kim , S Y , Han , H S , Kwon , Y Lee , K S . 2008 . Breast cancer subtypes and survival in patients with brain metastases . Breast Cancer Res , 10 : R20
   PubMed Web of Science ®Google Scholar
• Dent , R , Trudeau , M , Pritchard , K I , Hanna , W M Kahn , H K . 2007 . Triple-negative breast cancer: clinical features and patterns of recurrence . Clin Cancer Res , 13 : 4429 – 4434 .
   PubMed Web of Science ®Google Scholar
• Sakla , M S , Shenouda , N S , Ansell , P J , MacDonald , R S and Lubahn , D B . 2007 . Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells . Endocrine , 32 : 69 – 78 .
   PubMed Web of Science ®Google Scholar
• Yan , G R , Xiao , C L , He , G W , Yin , X F Chen , N P . 2010 . Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways . Proteomics , 10 : 976 – 986 .
   PubMed Web of Science ®Google Scholar
• Ouyang , G , Yao , L , Ruan , K , Song , G Mao , Y . 2009 . Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways . Cell Biol Int , 33 : 1237 – 11244 .
   PubMed Web of Science ®Google Scholar
• Rahal , O M and Simmen , R . 2010 . PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation . Carcinogenesis , 31 : 1491 – 1500 .
   PubMed Web of Science ®Google Scholar
• Katdare , M , Osborne , M and Telang , N T . 2002 . Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells . Int J Oncol , 21 : 809 – 815 .
   PubMed Web of Science ®Google Scholar
• Satoh , H , Nishikawa , K Suzuki , K . 2003 . Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent . Res Commun Mol Pathol Pharmacol , 113 : 149 – 158 .
   PubMedGoogle Scholar
• Su , S J , Chow , N H , Kung , M L , Hung , T C and Chang , K L . 2003 . Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity . Nutr Cancer , 45 : 113 – 123 .
   PubMed Web of Science ®Google Scholar
• Mai , Z , Blackburn , G and Zhou , J . 2007 . Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells . Mol Carcinogen , 46 : 534 – 542 .
   PubMed Web of Science ®Google Scholar
• Lattrich , C , Lubig , J , Springwald , A , Goerse , R Ortmann , O . 2011 . Additive effects of trastuzumab and genistein on human breast cancer cells . Anti-Cancer Drug , 22 : 253 – 261 .
   PubMed Web of Science ®Google Scholar
• Ju , Y H , Doerge , D R , Allred , K F , Allred , C D and Helferich , W G . 2002 . Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice . Cancer Res , 62 : 2474 – 2477 .
   PubMed Web of Science ®Google Scholar
• Suzuki , T , Matsuo , K , Tsunoda , N , Hirose , K Hiraki , A . 2008 . Effect of soybean on breast cancer according to receptor status: a case-control study in Japan . Int J Cancer , 123 : 1674 – 1680 .
   PubMed Web of Science ®Google Scholar